News
Having medical documents in place before a health crisis can help make tough decisions easier and less stressful for families.
“I’m hopeful,” Pramod said. It was early March and Luke had been waiting since New Year’s for insurance approval to continue ...
Mississippi is no stranger to criticism or being the butt of jokes alleging its inability or refusal to adapt with the times. And, while some of ...
Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...
Q2 2025 Earnings Call Transcript August 6, 2025 Delcath Systems, Inc. beats earnings expectations. Reported EPS is $0.06698, ...
On June 18, 2025, the Federal Ministry of Health (Bundesministerium für Gesundheit - BMG) published a draft bill proposing severe amendments to ...
Q2 2025 Earnings Call Transcript August 1, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, ...
The World Socialist Web Site interviewed Dr. Stephanie Woolhandler about the state of healthcare and the impact of Trump’s “One Big Beautiful Bill” (OBBB) on the healthcare industry. Dr. Woolhandler ...
European and FDA approval of Sephience (sepiapterin) with broad labeling for PKU - - Global launch underway in Europe and U.S. - - Total Q2 Revenue of $179M - ...
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.
Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results